Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
Go back to Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update| (NASDAQ: ACHV) | Delayed: 5.10 +0.25 (5.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $ | |||
| Open | $4.94 | 52 Week Low | $ | |||
| Day High | $5.43 | P/E | N/A | |||
| Day Low | $4.94 | EPS | $ | |||
| Volume | 2,899,433 | |||||

